Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass

NCT05487469 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT05487469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2022
Completion date
December 31, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, immunotherapy, rheumatic heart disease